Summit Therapeutics Inc.

Summit Therapeutics Inc.

290.00
MXN
0.00
(0.00%)
-19.29EPS
Mar 18Next Earn

Income Statement (USD)

2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
01/31/2011
01/31/2012
01/31/2013
01/31/2014
01/31/2015
01/31/2016
01/31/2017
01/31/2018
01/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
2
4
5
4
- -
- -
4
17
75
1
2
1
- -
- -
- -
+ Sales & Services Revenue
2
4
5
4
- -
- -
4
17
75
1
2
1
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
4
5
4
- -
- -
4
17
74
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
5
4
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- Operating Expenses
-6
12
11
18
18
42
42
51
62
53
88
64
89
211
1,094
+ Selling, General & Admin
- -
4
4
5
6
11
12
14
22
19
24
27
29
60
557
+ Research & Development
6
8
12
18
16
34
30
41
64
53
85
52
59
151
538
+ Other Operating Expense
-12
- -
-5
-5
-3
-2
- -
-4
-25
-19
-21
-14
- -
- -
- -
Operating Income (Loss)
8
-7
-11
-18
-18
-42
-38
-34
13
-52
-86
-64
-89
-211
-1,094
- Non-Operating (Income) Loss
23
- -
- -
- -
1
5
2
- -
1
1
2
15
526
10
-15
+ Interest Expense, Net
- -
- -
- -
- -
1
- -
1
1
1
- -
- -
3
6
-5
- -
+ Interest Expense
- -
- -
- -
- -
1
1
1
1
1
- -
- -
4
16
9
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
10
13
- -
+ Other Non-Op (Income) Loss
23
- -
- -
- -
- -
4
1
-1
- -
- -
2
12
520
15
-15
Pretax Income
-15
-7
-11
-18
-19
-47
-40
-34
12
-53
-89
-79
-615
-221
-1,080
- Income Tax Expense (Benefit)
-3
-1
-1
-2
-2
-6
-7
-5
-2
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-12
-7
-11
-17
-17
-41
-34
-29
14
-53
-89
-79
-615
-221
-1,080
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-12
-7
-11
-17
-17
-41
-34
-29
14
-53
-89
-79
-615
-221
-1,080
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-12
-7
-11
-17
-17
-41
-34
-29
14
-53
-89
-79
-615
-221
-1,080
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-12
-7
-11
-17
-17
-41
-34
-29
14
-53
-89
-79
-615
-221
-1,080
EBIT
-15
-7
-11
-18
-18
-41
-39
-37
7
-53
-86
-72
-610
-226
-1,094
EBITDA
-14
-7
-11
-18
-18
-41
-39
-36
10
-51
-84
-71
-609
-226
-1,094
EBITDA Margin (%)
-718.22
-159.43
-247.19
-486.04
- -
- -
-1,076.17
-205.74
12.86
-5,952.33
-4,628.58
-10,046.24
- -
- -
- -
EBITA
-15
-7
-11
-18
-18
-41
-39
-36
9
-52
-85
-71
-610
-226
-1,094
Gross Margin (%)
- -
100
100
100
- -
- -
100
99.44
99.96
- -
- -
- -
- -
- -
- -
Operating Margin (%)
429.75
-170.08
-252.04
-487.93
- -
- -
-1,055.56
-192.58
17.45
-6,081.63
-4,763.68
-9,024.26
- -
- -
- -
Profit Margin (%)
-614.68
-152.63
-232.91
-443.13
- -
- -
-927.56
-163.09
19.04
-6,127.56
-4,897.84
-11,174.75
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
90,568
230,200
- -
10,617
16,445
9,156
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
- -
- -
- -
- -
- -
- -
1
3
2
2
1
- -
- -
- -
Basic Weighted Avg Shares
168
187
4
409
8
59
62
65
86
69
92
193
620
719
748
Basic EPS, GAAP
-0.07
-0.04
-2.99
-0.04
-2.09
-0.69
-0.55
-0.44
0.17
-0.76
-0.96
-0.41
-0.99
-0.31
-1.44
Basic EPS from Cont Ops
-0.07
-0.04
-2.99
-0.04
-2.09
-0.69
-0.55
-0.44
0.17
-0.76
-0.96
-0.41
-0.99
-0.31
-1.44
Diluted Weighted Avg Shares
168
187
4
409
8
59
62
65
86
69
92
193
620
719
748
Diluted EPS, GAAP
-0.07
-0.04
-2.99
-0.04
-2.09
-0.69
-0.55
-0.44
0.17
-0.76
-0.96
-0.41
-0.99
-0.31
-1.44
Diluted EPS from Cont Ops
-0.07
-0.04
-2.99
-0.04
-2.09
-0.69
-0.55
-0.44
0.17
-0.76
-0.96
-0.41
-0.99
-0.31
-1.44

Balance Sheet (USD)

2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
01/31/2011
01/31/2012
01/31/2013
01/31/2014
01/31/2015
01/31/2016
01/31/2017
01/31/2018
01/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
9
7
10
8
23
42
52
51
80
88
97
657
190
424
720
+ Cash, Cash Equivalents & STI
8
5
8
6
17
33
44
28
46
66
72
349
186
412
713
+ Cash & Cash Equivalents
8
5
8
6
17
33
44
28
46
66
72
349
71
105
225
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
115
307
488
+ Accounts & Notes Receiv
- -
1
1
2
6
7
7
22
21
20
24
6
1
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
16
3
- -
1
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
1
1
2
6
7
7
7
18
19
23
6
1
1
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
- -
1
1
- -
2
1
- -
13
2
1
302
3
11
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
3
- -
11
6
9
7
27
24
15
16
7
13
12
31
+ Property, Plant & Equip, Net
1
- -
- -
- -
- -
- -
- -
3
3
1
3
5
6
6
22
+ Property, Plant & Equip
3
3
1
1
- -
1
- -
4
4
2
5
6
7
7
22
- Accumulated Depreciation
3
3
1
1
- -
1
- -
1
2
1
1
1
1
1
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
3
3
- -
11
6
8
7
24
21
14
13
2
7
6
9
+ Total Intangible Assets
3
3
- -
11
6
8
7
24
21
14
12
2
2
2
2
+ Goodwill
- -
- -
- -
2
1
1
1
4
3
2
2
2
2
2
2
+ Other Intangible Assets
3
3
- -
9
5
7
5
21
18
12
10
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
5
4
7
Total Assets
13
10
11
20
29
51
59
78
104
102
113
664
203
436
751
+ Payables & Accruals
- -
2
3
5
5
7
6
12
15
9
12
11
11
24
52
+ Accounts Payable
1
1
1
1
5
1
1
12
8
6
4
- -
3
5
20
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
3
4
- -
5
5
- -
7
3
7
11
9
20
32
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
21
3
4
3
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
20
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
2
3
4
3
+ Other ST Liabilities
3
1
- -
- -
- -
- -
11
20
7
10
13
6
6
14
17
+ Deferred Revenue
- -
1
1
- -
- -
- -
11
20
6
8
8
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
3
- -
-1
- -
- -
- -
- -
- -
1
2
5
6
6
14
17
Total Current Liabilities
3
3
4
5
5
7
17
33
23
20
26
39
20
42
73
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
1
1
- -
2
497
103
3
18
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
495
100
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
1
1
- -
2
3
3
3
18
+ Other LT Liabilities
1
1
- -
2
4
12
47
49
7
3
3
1
2
2
2
+ Accrued Liabilities
- -
- -
- -
2
1
1
38
42
4
1
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
1
1
- -
- -
3
10
9
7
3
3
3
1
2
2
2
Total Noncurrent Liabilities
1
1
- -
2
4
12
47
50
9
3
4
499
105
5
19
Total Liabilities
4
4
4
7
10
18
65
83
31
23
30
538
125
47
92
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
93
94
106
136
37
95
74
86
162
294
385
507
1,073
1,606
2,956
+ Common Stock
18
18
22
27
1
1
1
1
3
1
1
2
7
7
8
+ Additional Paid in Capital
75
76
84
109
36
93
73
85
160
293
384
505
1,066
1,598
2,948
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-82
-86
-98
-123
-49
-106
-116
-133
-131
-211
-300
-378
-993
-1,215
-2,294
+ Other Equity
- -
-5
-5
-5
27
37
28
33
40
-4
-2
-2
-2
-2
-3
Equity Before Minority Interest
9
6
7
13
20
33
-5
-4
73
79
83
127
78
389
659
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
9
6
7
13
20
33
-5
-4
73
79
83
127
78
389
659
Total Liabilities & Equity
13
10
11
20
29
51
59
78
104
102
113
664
203
436
751
Shares Outstanding
34
37
4
5
8
12
12
15
32
83
98
211
702
738
775
Number of Employees
- -
- -
- -
- -
- -
37
40
76
- -
81
110
77
105
159
265
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
2
2
- -
3
4
6
7
21
Net Debt
-8
-5
-8
-6
-17
-33
-44
-28
-46
-66
-72
166
29
-105
-225
Net Debt to Equity
-88.36
-86.28
-118.52
-42.63
-86.91
-101.39
803.38
637.75
-63.14
-83.59
-86.2
130.83
36.78
-26.97
-34.19
Tangible Common Equity Ratio
64.6
46.63
63.72
19.28
57.81
57.09
-22.8
-53.85
62.47
74.09
70.2
18.85
37.7
89.21
87.68
Current Ratio
3.09
2.06
2.74
1.66
4.26
6.5
3.06
1.56
3.56
4.41
3.8
16.93
9.3
10.15
9.87
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
01/31/2011
01/31/2012
01/31/2013
01/31/2014
01/31/2015
01/31/2016
01/31/2017
01/31/2018
01/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-15
-7
-11
-18
-19
-47
-40
-34
14
-53
-89
-79
-615
-221
-1,080
+ Depreciation & Amortization
1
- -
- -
- -
- -
- -
- -
1
3
2
2
1
- -
- -
- -
+ Non-Cash Items
1
1
3
1
3
11
9
6
9
2
14
26
538
64
725
+ Stock-Based Compensation
- -
- -
- -
1
1
2
2
2
8
2
13
12
14
51
732
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
2
- -
- -
- -
- -
- -
7
1
- -
8
- -
- -
- -
+ Other Non-Cash Adj
1
1
1
- -
2
8
7
4
-4
-1
1
6
524
13
-7
+ Chg in Non-Cash Work Cap
6
- -
- -
1
-1
2
50
7
-72
1
- -
10
-1
15
31
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
-3
- -
1
-13
-6
-4
-7
9
5
1
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
-3
2
1
-13
-2
- -
2
5
4
-7
5
+ Inc (Dec) in Accts Payable
- -
- -
- -
1
3
-1
1
5
- -
- -
7
2
- -
20
31
+ Inc (Dec) in Other
6
- -
- -
- -
3
- -
47
28
-64
5
-2
-7
-8
2
-5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-7
-6
-8
-16
-17
-35
19
-21
-46
-48
-73
-42
-77
-142
-323
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
- -
-1
- -
- -
-1
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
- -
-1
- -
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
4
13
13
33
53
- -
21
60
50
75
100
110
478
605
+ Increase in Capital Stock
- -
4
13
13
33
53
- -
21
60
50
75
100
110
478
605
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-113
-190
-174
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
208
490
311
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-321
-680
-485
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
-7
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
-7
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-475
-15
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
-7
- -
- -
- -
-1
-588
-205
-174
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
520
-25
-100
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
110
545
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
-110
-25
-25
-100
- -
+ Other Financing Activities
- -
- -
-1
-1
-2
-8
1
-1
-2
1
3
- -
2
3
13
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
3
11
12
30
45
1
19
58
51
78
620
87
381
618
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
-1
-3
-3
1
- -
-1
1
- -
- -
Net Changes in Cash
-7
-3
3
-4
14
10
20
-9
12
2
5
578
-578
34
120
EBITDA
-14
-7
-11
-18
-18
-41
-39
-36
10
-51
-84
-71
-609
-226
-1,094
EBITDA Margin (%)
-718.22
-159.43
-247.19
-486.04
- -
- -
-1,076.17
-205.74
12.86
-5,952.33
-4,628.58
-10,046.24
- -
- -
- -
Free Cash Flow
-7
-6
-8
-16
-17
-35
19
-21
-46
-49
-73
-42
-77
-142
-324
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
7
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
-7
-6
-8
-16
-17
-35
19
-21
-47
-49
-73
478
-101
-242
-324
Free Cash Flow per Basic Share
-0.04
-0.03
-2.31
-0.04
-2.02
-0.59
0.31
-0.32
-0.54
-0.7
-0.79
-0.22
-0.12
-0.2
-0.43
Price/Free Cash Flow
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-89.89
-45.23
Cash Flow to Net Income
0.58
0.9
0.75
0.96
0.97
0.85
-0.57
0.72
-3.23
0.91
0.82
0.53
0.12
0.64
0.3
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
-1
- -
- -
- -
-1
- -
- -
-1